Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report

Risk stratification for acute myeloid leukemia (AML) uses molecular and cytogenetic abnormalities identified at diagnosis. Response to therapy informs risk, and morphology continues to be used more frequently than flow cytometry. Herein, the largest cohort of pediatric patients prospectively assesse...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Brodersen, Lisa Eidenschink, Gerbing, Robert B., Pardo, M. Laura, Alonzo, Todd A., Paine, Dana, Fritschle, Wayne, Hsu, Fan-Chi, Pollard, Jessica A., Aplenc, Richard, Kahwash, Samir B., Hirsch, Betsy, Ramondi, Susana, Wells, Denise, Kolb, E. Anders, Gamis, Alan S., Meshinchi, Soheil, Loken, Michael R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2020
Konular:
Myeloid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594384/
https://ncbi.nlm.nih.gov/pubmed/33080007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002070
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller